In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Oxymag Drug Master File in Korea (Oxymag KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Oxymag. The MFDS reviews the Oxymag KDMF as part of the drug registration process and uses the information provided in the Oxymag KDMF to evaluate the safety and efficacy of the drug.
After submitting a Oxymag KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Oxymag API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Oxymag suppliers with KDMF on PharmaCompass.